First Karlijn Keijzer Scriptieprijs awarded to Lizeth Haveman
During the AIMMS annual meeting on 14 April 2016, the first Karlijn Keijzer Scriptieprijs will be presented to Lizeth Haveman, MSc student in Drug Discovery and Safety (DDS) at VU University.
03/24/2016 | 2:25 PM
This award is established in memory of Karlijn Keijzer, who was aboard the fatal MH17 flight, and it will be presented by Jacqueline Keijzer, the mother of Karlijn. Karlijn finished her MSc studies in DDS cum laude in 2012, with a specialization in Computational Medicinal Chemistry and Toxicology. For her PhD studies she joined the Computational Chemistry group of professor Baik at Indiana University in Bloomington, to study amongst other organometallic complexes of therapeutic interest. In September 2014 she was posthumously awarded her doctoral degree. As a PhD student Karlijn regularly visited VU University. In 2014 she obtained an Aspasia grant to stay with the Biocomputational Chemistry research group in the Division of Theoretical Chemistry.
In line with Karlijn’s intellectual legacy and interests and to stimulate other talented and ambitious students in their scientific development and (international) experience, the Karlijn Keijzer Scriptieprijs will be presented annually as a travel grant of EUR 1000. The award recipient will be selected by a jury based on excellence and motivation, and candidates must have successfully completed a BSc research project in the field of pharmaceutical sciences or (bio)chemistry. Supplemented by the VU Department of Chemistry and Pharmaceutical Sciences, resources for the award have been made available by the family from a donation fund for Karlijn.
This year the Karlijn Keijzer Scriptieprijs is awarded to Lizeth Haveman, who recently finished her BSc studies in Pharmaceutical Sciences cum laude, with excellent results in all sub-disciplines. Based on her study results, the jury considers Lizeth a highly talented student. She showed her strong motivation and ambitions by following an honours program comprising various additional courses in cross-disciplines. In addition, Lizeth performed two BSc research projects, in the Medicinal Chemistry (MEC) group and at the Radionuclide Center (RNC). She developed routes to synthesize small organic molecules that can switch receptor proteins on or off. The new molecular switches can be used to gain novel insights in the mechanism of action of receptor proteins involved in several diseases. With a radiolabel attached, the distribution of these molecules in the human body can be monitored. Besides her study results and research output, the jury members were also impressed by Lizeth’s clear scientific reports and they feel that with Lizeth Haveman the first Karlijn Keijzer Scriptieprijs is awarded to an excellent and highly motivated student. Lizeth has meanwhile successfully started the DDS MSc program (specialization: Design and Synthesis) and she intends to use the prize to finance a research internship abroad.